education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Lapibroz
Lapibroz
gemfibrozil
Manufacturer:
Lapi
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Gemfibrozil
Indications/Uses
Hypercholesterolemia, hypertriglyceridemia, dyslipidemia: Fredrickson type IIA, IIB, III, IV & V.
Dosage/Direction for Use
900-1,500 mg daily in 2 divided doses.
Administration
Should be taken on an empty stomach: Take 30 min before meals.
Contraindications
Renal dysfunction, severe hepatic, gallbladder disease.
Adverse Reactions
GI disturbance, nausea, dizziness.
View
ADR Reporting Link
Drug Interactions
Increase plasma conc of warfarin.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AB04 - gemfibrozil ; Belongs to the class of fibrates. Used in the treatment of hyperlipidemia.
Regulatory Classification
K
Presentation/Packing
Form
Lapibroz caplet 600 mg
Packing/Price
30's (Rp82,500/pak)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk